ABBV ready for shortABBV seems ready for short, RSI already broken trend line.
Details are on chart.
0.01BRL
24.08 BBRL
271.31 BBRL
About ABBVIE DRN
Sector
CEO
Richard A. Gonzalez
Headquarters
North Chicago
Website
Employees (FY)
50 K
Founded
2011
ISIN
BRABBVBDR001
FIGI
BBG00CRJ2Y32
AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology, oncology, including blood cancers, virology, hepatitis C virus (HCV) and human immunodeficiency virus (HIV), neurological disorders, such as Parkinson's, metabolic, comprising thyroid disease and complications associated with cystic fibrosis, pain associated with endometriosis, and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Curated watchlists where ABBV34 is featured.
